Deck Therapeutics
PrivateLast Round
Seed
Nov 10, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deck Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in November 2022.
Deck Therapeutics is a biotechnology company that develops acute omega-3 fatty acid therapeutics for the treatment of stroke and other acute organ injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deck Therapeutics Comparables
Compare Deck Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReAlta Life Sciences | 74% | |
| Tellus Therapeutics | 74% | |
| NoNO Inc. | 70% |
For institutional investors. Book with your work email.
Deck Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 10, 2022 | ||||
| Grant | Jul 8, 2022 |
For institutional investors. Book with your work email.
Deck Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalytic Impact Foundation | Seed |
| Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased by 50% MoM.
- Jan 6, 2026
Monthly visitors increased 413% MoM.
For institutional investors. Book with your work email.
Deck Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deck Therapeutics's valuation, stock price, and market status.
Is Deck Therapeutics a public or private company?
Deck Therapeutics is a private company.
What is the current stock price of Deck Therapeutics?
Deck Therapeutics is a private company, so its shares have no public market price. Caplight tracks Deck Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deck Therapeutics worth (valuation)?
Valuation information for Deck Therapeutics is not publicly available.
Can I buy Deck Therapeutics stock?
Deck Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deck Therapeutics's last funding round?
Deck Therapeutics's most recent funding round was Seed on November 10, 2022.
Who are the main investors in Deck Therapeutics?
Key investors in Deck Therapeutics include Catalytic Impact Foundation, Gates Foundation.
Will Deck Therapeutics IPO soon?
No public IPO plans have been announced for Deck Therapeutics.
How can I track Deck Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Deck Therapeutics's shares on secondary markets.